| 1 |
34188525 | Association Between PDL1 Genetic Variation and Efficacy of Apatinib Monotherapy in Patients with Previously Treated Advanced NSCLC: A Real-World Retrospective Study. | 2021 |
3 |
| 2 |
34429133 | Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer. | 2021 Aug 24 |
6 |
| 3 |
34742339 | Correction to: Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer. | 2021 Nov 6 |
1 |
| 4 |
34868934 | Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma. | 2021 |
2 |
| 5 |
35096582 | Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report. | 2021 |
1 |
| 6 |
33437808 | Complete response to immunotherapy combined with an antiangiogenic agent in multiple hepatic metastases after radical surgery for advanced gallbladder cancer: a case report. | 2020 Dec |
1 |
| 7 |
30755403 | Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer. | 2019 Apr |
1 |
| 8 |
29225166 | Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3. | 2018 Jan 8 |
1 |